HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lee T Zane Selected Research

crisaborole

12/2018Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families.
4/2018Early Relief of Pruritus in Atopic Dermatitis with Crisaborole Ointment, A Non-steroidal, Phosphodiesterase 4 Inhibitor.
10/2017Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis.
10/2016Tolerability of Crisaborole Ointment for Application on Sensitive Skin Areas: A Randomized, Double-Blind, Vehicle-Controlled Study in Healthy Volunteers.
9/2016Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.
7/2016Crisaborole Topical Ointment, 2% in Patients Ages 2 to 17 Years with Atopic Dermatitis: A Phase 1b, Open-Label, Maximal-Use Systemic Exposure Study.
4/2016Crisaborole Topical Ointment, 2%: A Nonsteroidal, Topical, Anti-Inflammatory Phosphodiesterase 4 Inhibitor in Clinical Development for the Treatment of Atopic Dermatitis.
3/2016Pharmacokinetic Profile, Safety, and Tolerability of Crisaborole Topical Ointment, 2% in Adolescents with Atopic Dermatitis: An Open-Label Phase 2a Study.
2/2016Post Hoc Analyses of the Effect of Crisaborole Topical Ointment, 2% on Atopic Dermatitis: Associated Pruritus from Phase 1 and 2 Clinical Studies.
12/2015A Phase 2, Randomized, Controlled, Dose-Ranging Study Evaluating Crisaborole Topical Ointment, 0.5% and 2% in Adolescents With Mild to Moderate Atopic Dermatitis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lee T Zane Research Topics

Disease

10Atopic Dermatitis (Atopic Eczema)
12/2018 - 10/2015
8Onychomycosis (Tinea Unguium)
02/2018 - 09/2014
7Acne Vulgaris
08/2008 - 10/2004
4Pruritus (Itching)
04/2018 - 02/2016
3Erythema
07/2015 - 06/2009
2Hirsutism
04/2016 - 01/2016
1Tinea Pedis (Athlete's Foot)
10/2017
1Psoriasis (Pustulosis Palmaris et Plantaris)
10/2016
1Insulin Resistance
04/2016
1Inflammation (Inflammations)
04/2016
1Dyslipidemias (Dyslipidemia)
04/2016
1Skin Diseases (Skin Disease)
03/2016
1Dermatitis
07/2015
1Telangiectasis (Telangiectasia)
06/2009
1Rosacea (Acne Rosacea)
06/2009
1Leukemia
02/2006

Drug/Important Bio-Agent (IBA)

11crisaboroleIBA
12/2018 - 10/2015
11Ointments (Pastes)IBA
12/2018 - 10/2015
8tavaboroleIBA
02/2018 - 09/2014
7Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
09/2016 - 10/2015
7BoronIBA
03/2016 - 09/2014
5Phosphodiesterase 4 InhibitorsIBA
12/2018 - 03/2016
5SolutionsIBA
02/2018 - 06/2015
5Pharmaceutical PreparationsIBA
03/2016 - 09/2014
3Antifungal AgentsIBA
02/2018 - 07/2015
3efinaconazoleIBA
10/2017 - 01/2016
3Isotretinoin (Accutane)FDA LinkGeneric
12/2007 - 06/2005
2Ciclopirox (Loprox)FDA LinkGeneric
10/2017 - 03/2016
1Testosterone (Sustanon)FDA Link
04/2016
1AllylamineIBA
03/2016
1AzolesIBA
03/2016
1AntipruriticsIBA
02/2016
1AndrogensIBA
01/2016
1EnzymesIBA
10/2015
1Pyridinolcarbamate (P23)IBA
08/2008
1Matrix Metalloproteinases (MMPs)IBA
01/2008
1RetinoidsIBA
05/2006
1tazarotene (Tazorac)FDA Link
10/2004

Therapy/Procedure

4Therapeutics
10/2017 - 05/2006
1Debridement
10/2017
1Lasers (Laser)
06/2009
1Dye Lasers
06/2009
1Drug Therapy (Chemotherapy)
02/2006